市场调查报告书
商品编码
1403341
全球医疗保健分析市场预测 (-2030):按类型、组件、部署模型、应用程式、最终用户和区域进行分析Healthcare Analytics Market Forecasts to 2030 - Global Analysis By Type, Component, Deployment Model, Application, End User and by Geography |
2023年,全球医疗保健分析市场规模为431亿美元,预计2030年将达到1,465.1亿美元,预测期内复合年增长率为19.1%。
有系统地应用资料分析工具和技术从庞大的医疗保健资料集提取模式、趋势和见解被称为医疗保健分析。医疗保健负责人可以利用高级分析、机器学习和统计建模的力量来做出改善患者治疗结果、业务效率和整体医疗保健服务的决策。此外,医疗保健分析对于将原始资料转化为可操作的资讯至关重要,从优化临床工作流程和确定成本节约策略到疾病预防的预测模型。
2018 年 6 月发布的 MedPac 报告发现,虽然死亡率和 ED/就诊率保持平稳,而再入院率下降,但每年可节省 20 亿美元,并且基于价值的支付表明这种转变正在取得进展。
不断增长的医疗资料
随着穿戴式科技、电子健康记录(EHR) 和其他数位健康工具的普及,医疗保健资料正以前所未有的速度成长。此外,医疗保健分析解决了从大量且多样化的资料中组织和获取有价值的见解的问题,以支持基于证据的决策并改善患者照护。
资料品质和互通性问题
分析中的医疗资料的安全性和隐私性不断受到日益复杂的网路威胁的挑战。核准的存取或资料外洩事件会使病患隐私面临风险,并降低对分析产品的信任。此外,解决此限制需要持续投资强大的网路安全措施、加密协议,并严格遵守资料保护标准,以降低资料安全漏洞的风险。
即时分析以促进更快的决策
透过整合医疗保健提供者的即时分析,可以实现快速、资料驱动的决策。这对于紧急应变和重症加护场景以及资源优化特别有用。此外,透过即时洞察,医护人员可以更快地回应病患病情的变化,并做出更好的整体临床决策。
指导不足和技能差距
缺乏具有医疗保健和分析经验的专业人员会造成人才缺口,从而危及成功实施分析倡议的能力。此外,医疗保健组织应投资于人才发展、学术伙伴关係和培训计划,以缩小技能差距,并确保医疗保健工作者拥有充分利用分析解决方案所需的技能。
医疗保健分析市场受到了 COVID-19 爆发的重大影响。随着人们对公共卫生的日益关注、对即时资料追踪和应对病毒的需求以及远端医疗服务的兴起,强大的分析解决方案变得越来越重要。政府、医疗机构和研究机构利用该分析来更好地分配资源、模拟病毒的传播并加快疫苗的分发。此外,COVID-19 的爆发加速了数位医疗技术的同化,从而增加了对分析工具的需求,以从海量的医疗记录中提取有意义的见解。
云端基础市场预计将在预测期内成为最大的细分市场
市场占有率最大的细分市场是云端基础的部署模型。云端基础的解决方案受到各行各业组织的高度青睐,因为它们提供了无与伦比的弹性、扩充性和可访问性。透过利用云端,企业可以从共用基础设施中受益,从而无需大量硬体支出和内部维护。此外,该模型透过支援对资料和应用程式的无缝远端访问,促进了快速变化的数位环境中的弹性和协作。
预计製药业在预测期内复合年增长率最高
预计製药业的复合年增长率最高。製药业正在迅速扩张,其特点是不断创新、研发工作以及寻找新的治疗方法。这种快速增长是由许多因素推动的,包括对生物製药的日益重视、精准医学的进步以及对新药的需求。此外,随着该产业应对大流行(COVID-19)等全球健康挑战,加速研发工作也推动了成长。
预计北美将占据全球医疗保健分析市场的最大份额。该地区的优势有许多因素,包括高度发展的医疗保健系统、尖端的技术力以及对研发的重视。尤其美国,是一个主要参与者,拥有大量的生物技术和製药公司、领先的医疗保健提供者和多元化的健康保险市场。此外,该地区还受益于医疗保健创新领域的稳定投资,并不断扩大市场占有率。
在全球医疗保健分析市场中,亚太地区的复合年增长率最高。许多关键因素推动了这种动态成长,包括中国和印度等国家的人口成长、医疗保健意识的提高以及医疗基础设施投资的增加。此外,该地区的製药和生技产业正在不断扩张,医疗保健技术取得了重大进步,各国政府正在采取积极措施来改善医疗保健的可及性。
According to Stratistics MRC, the Global Healthcare Analytics Market is accounted for $43.10 billion in 2023 and is expected to reach $146.51 billion by 2030 growing at a CAGR of 19.1% during the forecast period. The methodical application of data analysis tools and techniques to extract patterns, trends, and insights from enormous healthcare data sets is known as healthcare analytics. Healthcare practitioners can improve patient outcomes, operational efficiency, and overall healthcare delivery by leveraging the power of advanced analytics, machine learning, and statistical modeling to inform their decisions. Moreover, healthcare analytics is critical to turning raw data into actionable intelligence, from optimizing clinical workflows and identifying cost-saving strategies to predictive modeling for disease prevention.
According to the MedPac report published in June 2018, as the readmission rate declined, mortality rate and ED/observation rates were stable, but two billion dollars in annual savings was observed, showing that the shift to value-based payments is creating headway.
Data on healthcare has increased at a rate never seen before, thanks to the widespread use of wearable technology, electronic health records (EHRs), and other digital health tools. Additionally, in order to support evidence-based decision-making and improve patient care, healthcare analytics tackles the problem of organizing and deriving valuable insights from this enormous and varied data landscape.
The security and privacy of healthcare data in analytics are continuously challenged by the growing sophistication of cyber threats. Incidents of unapproved access and data breaches can jeopardize patient privacy and reduce confidence in analytics products. Furthermore, to mitigate the risk of data security breaches, addressing this constraint necessitates ongoing investment in strong cybersecurity measures, encryption protocols, and strict adherence to data protection standards.
The ability to make quick, data-driven decisions is made possible for healthcare providers by the integration of real-time analytics. This is especially helpful for emergency response, critical care scenarios, and resource optimization. Moreover, healthcare practitioners can respond more quickly to changes in patient conditions and make better clinical decisions overall when they have access to real-time insights.
The lack of professionals with both healthcare and analytics experience creates a talent gap that jeopardizes analytics initiatives' ability to be implemented successfully. Additionally, healthcare organizations need to make investments in workforce development, academic partnerships, and training programs in order to close skill gaps and guarantee that healthcare professionals have the skills needed to fully utilize analytics solutions.
The market for healthcare analytics has been significantly impacted by the COVID-19 pandemic. Robust analytics solutions have become increasingly important due to the growing emphasis on public health, the requirement for real-time data to track and respond to the virus, and the rise in telehealth services. Analytics has been used by governments, healthcare organizations, and researchers to better allocate resources, model viral spread, and expedite vaccine distribution. Furthermore, the COVID-19 pandemic has expedited the assimilation of digital health technologies, thereby elevating the need for analytics tools to extract meaningful insights from the flood of medical records.
The segment with the largest market share is the cloud-based deployment model. Organizations in a wide range of industries strongly prefer cloud-based solutions because they provide unmatched flexibility, scalability, and accessibility. By using the cloud, companies can benefit from a shared infrastructure, which eliminates the need for large hardware expenditures and internal maintenance. Moreover, this model fosters flexibility and collaboration in a digital landscape that is changing quickly by enabling seamless remote access to data and applications.
The pharmaceutical industry segment is projected to have the highest CAGR. The pharmaceutical sector is expanding rapidly, and it is distinguished by ongoing innovation, R&D efforts, and the search for novel treatments. This rapid growth can be attributed to a number of factors, such as the growing emphasis on biopharmaceuticals, advances in precision medicine, and the need for new drugs. Additionally, the growth has been further fueled by the industry's response to global health challenges, such as the COVID-19 pandemic, which has accelerated research and development efforts.
It is projected that North America will hold the largest market share for healthcare analytics worldwide. Numerous elements contribute to the region's dominance, such as its highly developed healthcare system, its cutting-edge technological capabilities, and its heavy emphasis on research and development. With its large number of biotechnology and pharmaceutical companies, state-of-the-art healthcare providers, and diverse health insurance market, the United States in particular is a key player. Furthermore, the area benefits from a steady stream of investments in healthcare innovation, which increases its market share.
In the global healthcare analytics market, the Asia-Pacific region has the highest CAGR. Numerous important factors, such as a growing population, rising healthcare awareness, and rising investments in healthcare infrastructure across nations like China and India, are driving this dynamic growth. Moreover, the pharmaceutical and biotechnology industries are expanding in the region, healthcare technology is advancing significantly, and the government is taking proactive steps to increase healthcare accessibility.
Some of the key players in Healthcare Analytics market include Evidation Health, Inc., Cerner Corporation, IBM Corporation, MedeAnalytics, Inc., GE Healthcare, McKesson Corporation, Komodo Health, Inc., Allscripts Healthcare Solution Inc, Optum, Inc., Athenahealth, Inc., Epic Systems Corporation
In June 2023, IBM announced that it has entered into a definitive agreement with Vista Equity Partners to purchase Apptio Inc., a leader in financial and operational IT management and optimization software, for $4.6 billion. The acquisition of Apptio will accelerate the advancement of IBM's IT automation capabilities and enable enterprise leaders to deliver enhanced business value across technology investments.
In May 2023, Evidation and Myovant Sciences Ltd., a wholly owned subsidiary of Sumitovant Biopharma Ltd. announced results from a survey exploring the lived experiences of individuals with endometriosis and/or uterine fibroids. The survey results highlight the negative impacts of these conditions on employee and student experiences and quality-of-life, underscoring the need for conversations and accommodations that advance equity for these populations.
In February 2023, Oracle Corp. has signed a contract with Accenture to improve the training Department of Veterans Affairs clinicians receive on using the VA's Cerner Millennium-based electronic health record platform. Speaking with FedScoop, Oracle Executive Vice President Ken Glueck said Oracle-owned Cerner had determined it needed additional support from consultancy firm Accenture after identifying this as an area where program improvement is needed.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.